New oral painkiller KHN702 enters human testing for Post-Op pain
NCT ID NCT07277933
First seen Jan 04, 2026 · Last updated Jun 20, 2026 · Updated 29 times
Summary
This early-stage trial tests a new oral drug called KHN702 for moderate to severe pain after surgery. About 24 adults will receive either the drug or a placebo to see if it is safe and helps reduce pain. The study is double-blind, meaning neither patients nor doctors know who gets the real drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KHN702 tablet
What this could lead to
If it works, this could lead to a new oral painkiller for post-surgery pain.
What could go wrong
This is a very early Phase 1 trial with only 24 people. It is designed mainly to check safety, not prove effectiveness. The drug may not work or could have side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.